Impact & research
What we're measuring. What we're finding.
We publish our methodology in full, even when results are unflattering.
12,400+
Lives in the system
97%
Cross-border continuity rate
0.84
Preeclampsia AUROC
78%
EPDS administered (PP6w)
Recent papers
Internal · pre-publication
2026-03-22Preeclampsia risk model: 18-month retrospective validation
0.84 AUROC on 4,200-pregnancy cohort. False-positive rate held under 8%.
Request PDFInternal · pre-publication
2026-02-04Cross-border continuity outcomes, Yuma, San Luis Río Colorado pilot
97% of cross-border records arrived intact at the receiving facility within 4 hours of consent.
Request PDFAMIA Annual Symposium 2025
2025-11-14Bilingual voice-first intake: a randomized comparison
Spanish-first patients completed intake 1.6× faster with voice than typed.
Request PDFWant to collaborate?
We work with academic partners on real-world evidence studies for maternal-fetal outcomes. We'll share our data lake under DUA.
Get in touch